Brazil Radiotherapy Market Report 2022 to 2030

Brazil Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Brazil Radiotherapy Market will reach a value of $297 Mn from $173 Mn in 2022, growing at a CAGR of 7% during 2022-30. The Radiotherapy Therapeutics Market in Brazil is dominated by a few domestic players such as Accuray, Varian Medical Systems, and Accuray. The radiotherapy market in Brazil is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Brazil Radiotherapy is increasing on account of the rise in cancer cases in the country.

ID: IN10BRPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Brazil AUTHOR: Dr. Vishwa Modhia

Buy Now

Brazil Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Brazil Radiotherapy Market will reach a value of $297 Mn from $173 Mn in 2022, growing at a CAGR of 7% during 2022-30.

Brazil is an upper middle-income, developing and the largest country in South America bounded by the Atlantic Ocean. In Brazil, 600,000 additional cancer cases were expected to be detected each year in 2018 and 2019. Cancer care in Brazil was mostly funded by philanthropic organizations from the early twentieth century until 1937. That year, the National Cancer Institute was founded with a distinct function in policymaking, but the status quo of care remained constant.

Cancer therapy is provided via high-complexity oncology centers (Centros de Assistência de Alta Complexidade em Oncologia-CACONs), high-complexity oncology units (Unidades de Assistência de Alta Complexidade em Oncologia-UNACONs), and hospital complexes. Brazil's government spent 10.3 % of its GDP on healthcare in 2020.

Brazil Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Radiotherapy is crucial in the treatment of diseases that are common in Brazil (e.g., prostate and breast cancer), and it has a significant impact on clinical results. The Radiotherapy Expansion Plan for Brazil's Unified Health System (PER-SUS) was an innovative programme created by the Ministry of Health in 2012 to address the country's difficult problem of radiotherapy access. These aspects could boost Brazil's Radiotherapy Market.

Market restraints

In Brazil, there is a significant disparity between the distribution of cancer cases and the availability of LINAC. After ten years, the PER-SUS project had provided about half of the expected radiation equipment implementation. The national number of LINACS with PER-SUS increased by 17%, compared to a 32% increase in cancer incidence in Brazil during the same time period. However, just 269 machines were available in 2014 for Brazil's Unified Health System (Sistema Unico de Sade - SUS), representing 62% of the required capacity. However, only 145,000 patients (56% of all SUS patients) were able to complete their radiation treatments by the end of 2015. 4 Approximately 5,000 individuals died in 2016 as a result of a shortage of access to radiation. These factors may deter new entrants into the Brazil Radiotherapy Market.

Competitive Landscape

Key Players

Accuray: A US-based company that specializes in radiation oncology treatments, Accuray has a significant presence in Brazil. Its products include the CyberKnife and the TomoTherapy systems
Elekta: Another US-based company, Elekta has a strong presence in Brazil's radiotherapy market. Its products include the Leksell Gamma Knife, the Versa HD, and the Elekta Synergy
Varian Medical Systems: A global leader in radiation oncology solutions, Varian has been active in Brazil for more than 50 years. Its products include the TrueBeam and the Halcyon
Brainlab: A German company that offers software and hardware solutions for radiotherapy and radiosurgery, Brainlab has been operating in Brazil since 1999
Oncovida: A Brazilian company that offers radiation therapy services, Oncovida has clinics in several locations across Brazil
Hospital do Cancer de Barretos: A Brazilian cancer centre that offers a wide range of treatments, including radiation therapy

Recent Notable Updates

July 2022: Clinicians at the Brazilian Hospital Unimed Bauru use Elekta's unique EPID-based patient QA software to easily check RT beams before treatment. EPIbeam calculates the dose supplied using Linac's EPID panel and does not require the usage of a phantom. It compares the delivered dose to the planned dose automatically.

Healthcare Policies and Reimbursement Scenarios

Brazil has a public health system called Sistema Único de Saúde (SUS) that provides radiotherapy services for free. The Brazilian Ministry of Health regulates radiotherapy services in Brazil. The Brazilian National Cancer Institute (INCA) is responsible for developing and coordinating national policies for cancer prevention and control. Radiotherapy in Brazil is regulated by the National Health Surveillance Agency (ANVISA), which is responsible for overseeing the safety and effectiveness of medical devices used in radiation therapy, as well as the licensing of radiation therapy facilities.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.